Published in Biochem Soc Trans on February 01, 2006
A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature (2015) 3.51
Molecular interactions between the specialist herbivore Manduca sexta (Lepidoptera, Sphingidae) and its natural host Nicotiana attenuata. VII. Changes in the plant's proteome. Plant Physiol (2006) 1.59
A mechanism for the evolution of phosphorylation sites. Cell (2011) 1.47
Diphthamide modification of eEF2 requires a J-domain protein and is essential for normal development. J Cell Sci (2008) 1.08
Phosphorylation of eukaryotic elongation factor 2 (eEF2) by cyclin A-cyclin-dependent kinase 2 regulates its inhibition by eEF2 kinase. Mol Cell Biol (2012) 1.05
The role of protein synthesis in cell cycling and cancer. Mol Oncol (2009) 1.03
EEF2 analysis challenges the monophyly of Archaeplastida and Chromalveolata. PLoS One (2008) 0.98
Diversity and impact of prokaryotic toxins on aquatic environments: a review. Toxins (Basel) (2010) 0.94
The biosynthesis and biological function of diphthamide. Crit Rev Biochem Mol Biol (2013) 0.92
Alcohol intoxication following muscle contraction in mice decreases muscle protein synthesis but not mTOR signal transduction. Alcohol Clin Exp Res (2015) 0.87
Molecular control of the amount, subcellular location, and activity state of translation elongation factor 2 in neurons experiencing stress. Free Radic Biol Med (2013) 0.86
Regulation of protein synthesis by amino acids in muscle of neonates. Front Biosci (Landmark Ed) (2011) 0.85
Recent insights into Pasteurella multocida toxin and other G-protein-modulating bacterial toxins. Future Microbiol (2010) 0.85
Proteomic evaluation and validation of cathepsin D regulated proteins in macrophages exposed to Streptococcus pneumoniae. Mol Cell Proteomics (2011) 0.84
Endocannabinoid-dependent homeostatic regulation of inhibitory synapses by miniature excitatory synaptic activities. J Neurosci (2009) 0.84
Elongation factor 2 diphthamide is critical for translation of two IRES-dependent protein targets, XIAP and FGF2, under oxidative stress conditions. Free Radic Biol Med (2013) 0.83
p38δ MAPK: Emerging Roles of a Neglected Isoform. Int J Cell Biol (2014) 0.81
HIV-1 viral protein R (Vpr) and its interactions with host cell. Curr HIV Res (2009) 0.81
Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid mediates protective effects through regulation of the ERK pathway. Free Radic Biol Med (2008) 0.81
A structural domain mediates attachment of ethanolamine phosphoglycerol to eukaryotic elongation factor 1A in Trypanosoma brucei. PLoS One (2010) 0.79
Kinetics of initiating polypeptide elongation in an IRES-dependent system. Elife (2016) 0.79
Identification and optimization of classifier genes from multi-class earthworm microarray dataset. PLoS One (2010) 0.79
To be or not to be: the regulation of mRNA fate as a survival strategy during mammalian hibernation. Cell Stress Chaperones (2014) 0.78
Chemical and functional aspects of posttranslational modification of proteins. Acta Naturae (2009) 0.77
Afferent regulation of chicken auditory brainstem neurons: rapid changes in phosphorylation of elongation factor 2. J Comp Neurol (2013) 0.77
Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cells. Mol Cell Proteomics (2015) 0.76
Gene expression profile of whole blood cells differs in pregnant women with positive screening and negative diagnosis for gestational diabetes. BMJ Open Diabetes Res Care (2016) 0.75
Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC. Oncotarget (2017) 0.75
Bacterial polypeptide release factor RF2 is structurally distinct from eukaryotic eRF1. Mol Cell (2001) 1.86
Structure and dynamics of the colicin E1 channel. Mol Microbiol (1990) 1.19
Mapping the membrane topology of the closed state of the colicin E1 channel. J Biol Chem (1994) 1.05
Application of a fluorometric assay for characterization of the catalytic competency of a domain III fragment of Pseudomonas aeruginosa exotoxin A. Anal Biochem (2001) 1.00
Bundling post-acute care (PAC) with Medicare DRG payments: an exploration of the distributional and risk consequences. Inquiry (1996) 0.99
Investigation into the catalytic role for the tryptophan residues within domain III of Pseudomonas aeruginosa exotoxin A. Biochemistry (1996) 0.95
Fourier transform infrared evidence for a predominantly alpha-helical structure of the membrane bound channel forming COOH-terminal peptide of colicin E1. Biophys J (1991) 0.95
Protein-protein interaction using tryptophan analogues: novel spectroscopic probes for toxin-elongation factor-2 interactions. Biochemistry (2001) 0.93
Types I and III procollagen extension peptides in serum respond to fracture in humans. Arch Orthop Trauma Surg (1992) 0.92
The colicin E1 insertion-competent state: detection of structural changes using fluorescence resonance energy transfer. Biochemistry (1994) 0.91
Identification of a role for actin in translational fidelity in yeast. Mol Genet Genomics (2002) 0.88
A catalytic loop within Pseudomonas aeruginosa exotoxin A modulates its transferase activity. J Biol Chem (2001) 0.86
Structure, function and control of complement C5 and its proteolytic fragments. Curr Mol Med (2012) 0.86
Crystallization of the yeast elongation factor complex eEF1A-eEF1B alpha. Acta Crystallogr D Biol Crystallogr (2001) 0.83
In vitro enzyme activation and folded stability of Pseudomonas aeruginosa exotoxin A and its C-terminal peptide. Biochemistry (1996) 0.83
Guanidine hydrochloride-induced denaturation of the colicin E1 channel peptide: unfolding of local segments using genetically substituted tryptophan residues. Biochemistry (1995) 0.83
Adventures in membrane protein topology. A study of the membrane-bound state of colicin E1. J Biol Chem (1999) 0.83
Dynamic properties of the colicin E1 ion channel. FEMS Microbiol Immunol (1992) 0.83
A fluorescence investigation of the active site of Pseudomonas aeruginosa exotoxin A. J Biol Chem (1999) 0.81
Site-directed mutagenesis of the charged residues near the carboxy terminus of the colicin E1 ion channel. Biochemistry (1988) 0.80
Solution NMR studies of colicin E1 C-terminal thermolytic peptide. Structural comparison with colicin A and the effects of pH changes. Eur J Biochem (1990) 0.78
Characterization of an unfolding intermediate and kinetic analysis of guanidine hydrochloride-induced denaturation of the colicin E1 channel peptide. Biochemistry (1997) 0.78
Functional and social long-term results after free tissue transfer to the lower extremity. Ann Plast Surg (1995) 0.78
Evidence for the modulation of Pseudomonas aeruginosa exotoxin A-induced pore formation by membrane surface charge density. Biochemistry (1994) 0.77
Relation between Ca2+ uptake and fluidity of brush-border membranes isolated from rabbit small intestine and incubated with fatty acids and methyl oleate. Biochim Biophys Acta (1987) 0.77
An enzyme-linked immunosorbent assay for the association of the catalytic domain of diphthamide-specific ribosyltransferases to eukaryotic elongation factor-2. Anal Biochem (1999) 0.77
Colicin E1 forms a dimer after urea-induced unfolding. Biochem J (1999) 0.76
Integrated light-scattering spectroscopy, a sensitive probe for peptide-vesicle binding: application to the membrane-bound colicin E1 channel peptide. Biophys J (1995) 0.75
Effects of exogenous fatty acids on calcium uptake by brush-border membrane vesicles from rabbit small intestine. Biochim Biophys Acta (1986) 0.75
Studies on calcium binding to brush-border membranes from rabbit small intestine. Biochim Biophys Acta (1986) 0.75
The discovery of moriniafungin, a novel sordarin derivative produced by Morinia pestalozzioides. Bioorg Med Chem (2005) 0.75
A comparison of brush-border membranes prepared from rabbit small intestine by procedures involving Ca2+ and Mg2+ precipitation. Biochim Biophys Acta (1986) 0.75
Overproduction and purification of the colicin E1 immunity protein. Plasmid (1993) 0.75
[Primary assessment of X-ray images in a casualty department]. Ugeskr Laeger (1990) 0.75
Crystallisation and preliminary X-ray analysis of the receptor-binding domain of human and bovine alpha 2-macroglobulin. FEBS Lett (1995) 0.75
Crystallization of human methylamine-treated complement C3 and C3b. Acta Crystallogr D Biol Crystallogr (1994) 0.75
[Idiopathic scolioses]. Ugeskr Laeger (1993) 0.75
Membrane-inserted colicin E1 channel domain: a topological survey by fluorescence quenching suggests that model membrane thickness affects membrane penetration. J Nat Toxins (1998) 0.75
[Prevalence of idiopathic scoliosis in the municipality of Hillerod]. Ugeskr Laeger (2000) 0.75
[Idiopathic scolioses treated with the Boston brace]. Ugeskr Laeger (1993) 0.75